Navigation

Summary of Results

Health Topic:   Musculoskeletal
Guidance:   Ankylosing spondylitis - adalimumab, etanercept and infliximab
Description:   The summary of the published technology appraisal on Ankylosing spondylitis - adalimumab, etanercept and infliximab. It links to the published guidance and key documents.

NICE implementation uptake reports

Implementation uptake report Assessment Published Date Coverage

External literature

External literature Assessment Coverage

Richards, M (2010) Extent and causes of international variation in drug usage: A report for the Secretary of State for Health by Professor Sir Mike Richards CBE

Description: This report looks at medicines usage between countries, using IMS Health data. The WHO defined daily dose or the maximum or prescribed daily dose was used to measure usage. Results rank the UK relative to other countries usage and present calculations showing how close or otherwise the UK is to the average use across groups of other countries. It should be noted that countries other than the UK would not be expected to adhere to NICE guidance making comparisons between countries not possible.

Not graded National

Richards, M (2010) Extent and causes of international variation in drug usage: A report for the Secretary of State for Health by Professor Sir Mike Richards CBE

Description: This report looks at medicines usage between countries, using IMS Health data. The WHO defined daily dose or the maximum or prescribed daily dose was used to measure usage. Results rank the UK relative to other countries usage and present calculations showing how close or otherwise the UK is to the average use across groups of other countries. It should be noted that countries other than the UK would not be expected to adhere to NICE guidance making comparisons between countries not possible.

Not graded National

Rees, F. et al (2012) Compliance with NICE guidance on the use of anti-TNFalpha agents in ankylosing spondylitis: An East and West Midlands regional audit. Clinical Medicine, Journal of the Royal College of Physicians of London. 12 (4) (pp 324-327), 2012.

Description: This regional audit examined compliance with NICE guidelines for the use of anti-TNFs in treating patients with ankylosing spondylitis (AS). Data from 17 rheumatology centres across the midlands were collected during July 2010. The audit found that of all patients currently taking anti-TNF agents, 46% (128/275) had regular 12-weekly assessments documented in their notes. This ranged from 8%-100% between units.

Doubts about or mixed impact in practice Regional

This page was last updated: 01 August 2012

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.